| Name | Title | Contact Details |
|---|
Regenco is a Milwaukee, WI-based company in the Business Services sector.
david j murray and associates is a Princeton, NJ-based company in the Business Services sector.
Founded in 1978, Domino Printing Sciences plc, has established a global reputation for the continual development and manufacture of its total coding and printing technologies that meet the needs of manufacturers and sets new industry standards in quality and reliability. Through a global network of 25 subsidiary offices and in excess of 200 distributors, Domino Printing Sciences plc sells to over 120 countries offering extensive customer support. In 2014, Domino Printing Sciences plc achieved a turnover of £350.2 million; it is listed in the FTSE 250 share index on the London Stock Exchange (share code DNO). The Group employs 2,300 people worldwide with manufacturing facilities situated in UK, China, Germany, India, Sweden and USA.
Quantum Color Graphics Inc is a Morton Grove, IL-based company in the Business Services sector.
Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. The XmAb® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by Xencor and by pharmaceutical partners. Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs.